190 related articles for article (PubMed ID: 16800912)
1. [New principles in tumor antigens and their significance in future immunotherapies for lymphomas and other malignancies--editorial].
Ke XY; Wang J; Yang XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):419-26. PubMed ID: 16800912
[TBL] [Abstract][Full Text] [Related]
2. New concepts in tumor antigens: their significance in future immunotherapies for tumors.
Yang F; Yang XF
Cell Mol Immunol; 2005 Oct; 2(5):331-41. PubMed ID: 16368059
[TBL] [Abstract][Full Text] [Related]
3. Identifying tumor antigens in endocrine malignancies.
Wuttke M; Papewalis C; Jacobs B; Schott M
Trends Endocrinol Metab; 2009 Apr; 20(3):122-9. PubMed ID: 19269848
[TBL] [Abstract][Full Text] [Related]
4. Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies.
Braun DA; Wu CJ
Cancer J; 2017; 23(2):115-124. PubMed ID: 28410299
[TBL] [Abstract][Full Text] [Related]
5. The development of new cancer therapies based on the molecular identification of cancer regression antigens.
Rosenberg SA
Cancer J Sci Am; 1995; 1(2):90-100. PubMed ID: 9166458
[TBL] [Abstract][Full Text] [Related]
6. Immunotheranostics: breaking tolerance in immunotherapy using tumor autoantigens identified on protein microarrays.
Chatterjee M; Draghici S; Tainsky MA
Curr Opin Drug Discov Devel; 2006 May; 9(3):380-5. PubMed ID: 16729735
[TBL] [Abstract][Full Text] [Related]
7. Cancer vaccines and immunotherapies: emerging perspectives.
Henderson RA; Mossman S; Nairn N; Cheever MA
Vaccine; 2005 Mar; 23(17-18):2359-62. PubMed ID: 15755628
[TBL] [Abstract][Full Text] [Related]
8. [Immunotherapy for cancer--modern immunologic strategies in oncology].
Halama N; Zoernig I; Jäger D
Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
[TBL] [Abstract][Full Text] [Related]
9. Tumor immunology.
Shu S; Plautz GE; Krauss JC; Chang AE
JAMA; 1997 Dec; 278(22):1972-81. PubMed ID: 9396660
[TBL] [Abstract][Full Text] [Related]
10. Identification of human tumor antigens recognized by T-cells and their use for immunotherapy.
Kawakami Y
Int J Hematol; 2003 Jun; 77(5):427-34. PubMed ID: 12841379
[TBL] [Abstract][Full Text] [Related]
11. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.
Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ
J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880
[TBL] [Abstract][Full Text] [Related]
12. Editorial: international reviews of immunology.
Internati MC; Mirandola L; Bot A
Int Rev Immunol; 2014 Oct; 33(5):365-6. PubMed ID: 25277338
[No Abstract] [Full Text] [Related]
13. Tumor rejection antigens and tumor specific cytotoxic T lymphocytes.
Toes RE; Offringa R; Feltkamp MC; Visseren MJ; Schoenberger SP; Melief CJ; Kast WM
Behring Inst Mitt; 1994 Jul; (94):72-86. PubMed ID: 7998917
[TBL] [Abstract][Full Text] [Related]
14. Next-generation immunotherapies for lymphoma: one foot in the future.
Manson G; Houot R
Ann Oncol; 2018 Mar; 29(3):588-601. PubMed ID: 29365060
[TBL] [Abstract][Full Text] [Related]
15. The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens.
Rosenberg SA
Annu Rev Med; 1996; 47():481-91. PubMed ID: 8712798
[TBL] [Abstract][Full Text] [Related]
16. [NY-ESO-1 and cancer immunotherapy].
Peng JR; Leng XS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):371-7. PubMed ID: 18795604
[TBL] [Abstract][Full Text] [Related]
17. Antigens for cancer immunotherapy.
Neller MA; López JA; Schmidt CW
Semin Immunol; 2008 Oct; 20(5):286-95. PubMed ID: 18951039
[TBL] [Abstract][Full Text] [Related]
18. [Oncoimmunology: some fundamental problems of cancer immunotherapy].
Nedospasov SA; Kuprash DV
Mol Biol (Mosk); 2007; 41(2):355-68. PubMed ID: 17514902
[TBL] [Abstract][Full Text] [Related]
19. Model of stimulation-responsive splicing and strategies in identification of immunogenic isoforms of tumor antigens and autoantigens.
Yang F; Chen IH; Xiong Z; Yan Y; Wang H; Yang XF
Clin Immunol; 2006 Nov; 121(2):121-33. PubMed ID: 16890493
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive mechanisms in human tumors: why we still cannot cure cancer.
Gross S; Walden P
Immunol Lett; 2008 Feb; 116(1):7-14. PubMed ID: 18164076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
